Due to lower financing costs, Sing Investments & Finance was able to report a slight increase of 2% y-o-y for its 2HFY2025 bottom line, despite a lower topline and a jump in provision for credit allowances.
For the half year ended Dec 31 2025, net profit after tax was $20.6 million, versus $20.3 million in the year-earlier 1HFY2024.
Its interest income and hiring charges for the period was $67.1 million, down 13% y-o-y. Interest expense, meanwhile, dropped 36% to $27.4 million amid a lower interest rate environment.
However, the company made a $4.78 million provision, versus an "immaterial" write-back of $13,000 in the year-earlier period.
With the latest 2HFY2025 numbers, the company's full-year earnings increased by 16% to $42.3 million.
SingFinance plans to pay a higher dividend of 7.5 cents per share, up from 6.5 cents paid for FY2024.
See also: Raffles Medical posts 13.4% growth in FY2025 earnings to $70.6 mil
In its earnings commentary, SingFinance warns that downside risks remain this year.
As such, the company is keeping a "cautious" outlook for 2026, recognising that significant challenges and uncertainties persist.
"In the new year, we will remain steadfast in managing our risk exposures in a prudent manner and seek to maintain our strong capital and liquidity positions for sustainable growth," says SingFinance.
Sing Investments & Finance shares closed at $1.73, up 2.37%.
